Ultragenyx Pharmaceutical (RARE) Operating Income (QoQ) (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) Operating Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.73 Bn | 2.31 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.18% |
| Dec 31, 2025 | 33.71% |
| Sep 30, 2025 | -58.40% |
| Jun 30, 2025 | 24.55% |
| Mar 31, 2025 | -16.92% |
| Dec 31, 2024 | 7.34% |
| Sep 30, 2024 | -13.43% |
| Jun 30, 2024 | 29.63% |
| Mar 31, 2024 | -35.71% |
| Dec 31, 2023 | 16.03% |
| Sep 30, 2023 | 1.93% |
| Jun 30, 2023 | 3.99% |
| Mar 31, 2023 | -5.82% |
| Dec 31, 2022 | 35.30% |
| Sep 30, 2022 | -58.95% |
| Jun 30, 2022 | -3.63% |
| Mar 31, 2022 | -33.22% |
| Dec 31, 2021 | -14.18% |
| Sep 30, 2021 | -8.52% |
| Jun 30, 2021 | 22.33% |